To access this element change to forms mode OFF
Grant Award View - GA30130
"Fine-tuned" manipulation of the c-MET oncogenic pathway in pancreatic...
GA ID:
GA30130
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$707,521.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
"Fine-tuned" manipulation of the c-MET oncogenic pathway in pancreatic cancer: a new paradigm of personalised medicine.
Purpose:
Only 8 percent of patients with pancreatic cancer (PC) survive the disease, and current therapies, tested in all-comers, have limited success. More than a third of patients with PC may benefit from a novel combination therapy of agents that target cancer cell growth and survival. Significance of our work lies in identifying treatment strategies that can be directed to PC patients in a subgroup-selective manner, ultimately leading to reductions in the mortality associated with this lethal cancer.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1162860
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Garvan Institute of Medical Research
Recipient ABN:
62 330 391 937
Grant Recipient Location
Suburb:
Darlinghurst
Town/City:
Darlinghurst
Postcode:
2010
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA